Weekly Spotlight - 07.11.24

Community

We want to hear your story!

Fill in the form to share your experiences and any challenges you’ve faced living with your condition, for a chance to be featured in one of our weekly newsletters!

In the News

Coping with Mental Health and Blood Cancer: A Personal Journey

Living with bipolar disorder and blood cancer, the author shares their journey of diagnosis, treatment, and recovery. They highlight the importance of seeking help, therapy, and support from loved ones. Creative outlets and community involvement have been vital in managing mental health and overcoming challenges, fostering resilience and hope.

Acalabrutinib Shows Promise in Safety for Mantle Cell Lymphoma Patients

Acalabrutinib and ibrutinib show similar effectiveness in treating relapsed/refractory mantle cell lymphoma, but acalabrutinib offers a safer profile. The study highlights acalabrutinib's lower risk of severe side effects, providing hope for patients seeking safer treatment options. This analysis reassures patients and families about the potential benefits of acalabrutinib.

New Hope for B-cell Lymphoma Patients with BYON4228 Trial

The phase 1 trial of BYON4228, a humanised monoclonal antibody, aims to find the best dose and assess safety and effectiveness for B-cell non-Hodgkin lymphoma patients. Eligible participants have not responded to two treatments. Recruitment is ongoing in Manchester and Plymouth. More details are available online.

Christmas Raffle: Win Cash Prizes and Support Lymphoma Action

Join Lymphoma Action's 2024 Christmas Raffle to win cash prizes, including £1,500. Your participation supports those affected by lymphoma, funding vital resources like medical information, helpline calls, and online support meetings. Every ticket purchased aids the UK's fifth most common cancer, offering hope and connection year-round.